UNSPSC 41131707: Factor v leiden dna mutation detection systems

In this classification Factor V Leiden deoxyribonucleic acid (DNA) mutation detection systems are devices that consist of different reagents and instruments which include polymerase chain reaction (PCR) primers, hybridization matrices, thermal cyclers, imagers, and software packages US FDA regulates Factor v leiden dna mutation detection systems under 21 CFR 864.7280 and under FDA product code NPQ.

UNSPSC 41131707 Factor v leiden dna mutation detection systems is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes laboratory diagnostic systems for detecting Factor V Leiden DNA mutations—a hereditary blood clotting disorder—yet the recent opportunities posted under this code span offender drug testing, naloxone procurement, forensic drug standards, employment physicals, breath alcohol testing equipment, and employment screening services. None of these solicitations involve Factor V Leiden detection or genetic mutation analysis. The issuing bodies comprise county community supervision departments, county health and criminal justice operations, state departments, and public higher-education institutions across Texas, Florida, Oregon, and Nevada. The mismatch between the code's nominal scope and the actual work being solicited suggests either systematic miscoding in the state and local procurement systems or a data classification error in the source. Without recent opportunities genuinely soliciting Factor V Leiden detection systems or related genetic diagnostics, this code shows no active procurement interest aligned with its technical definition.

The most recent opportunities tagged under this code include Collin County, Texas requesting offender specimen collection and drug testing services (RFP 2026-327, due July 23, 2026, estimated contract value $600,000); Benton County, Oregon soliciting urinalysis testing for a family treatment court program (RFP, due July 6, 2026); Pinellas County, Florida procuring certified drug reference standards for forensic analysis (ITQ 26-0305-ITQ, due April 23, 2026, funded through the Paul Coverdell Forensic Sciences Improvement Act); and City Colleges of Chicago requesting employment screening and drug testing services (RFP MWJ2603, due March 30, 2026, with 25% MBE and 7% WBE participation goals). The Nevada Department of Public Safety also posted two solicitations in January and February 2026 for Intoxilyzer 9000 breath alcohol testing devices and associated printers. These opportunities reflect criminal justice, occupational health, and forensic laboratory procurement patterns—none of which align with genetic mutation detection. Firms pursuing this code should treat the recent activity as a signal that the UNSPSC classification requires clarification from the issuing procurement offices before developing a market strategy.